These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 3953889)

  • 1. Proposed changes in DSM-III substance use disorders: description and rationale.
    Rounsaville BJ; Spitzer RL; Williams JB
    Am J Psychiatry; 1986 Apr; 143(4):463-8. PubMed ID: 3953889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A field trial of DSM-III-R psychoactive substance dependence disorders.
    Rounsaville BJ; Kosten TR; Williams JB; Spitzer RL
    Am J Psychiatry; 1987 Mar; 144(3):351-5. PubMed ID: 3826436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agreement between DSM-III and III-R substance use disorders.
    Cottler LB; Helzer JE; Mager D; Spitznagel EL; Compton WM
    Drug Alcohol Depend; 1991 Dec; 29(1):17-25. PubMed ID: 1797516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CIDI-core substance abuse and dependence questions: cross-cultural and nosological issues. The WHO/ADAMHA Field Trial.
    Cottler LB; Robins LN; Grant BF; Blaine J; Towle LH; Wittchen HU; Sartorius N
    Br J Psychiatry; 1991 Nov; 159():653-8. PubMed ID: 1756341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should tolerance and withdrawal be required for substance dependence disorders?
    Carroll KM; Rounsaville BJ; Bryant KJ
    Drug Alcohol Depend; 1994 Aug; 36(1):15-22. PubMed ID: 7988354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications for four drugs of the DSM-IV distinction between substance dependence with and without a physiological component.
    Schuckit MA; Daeppen JB; Danko GP; Tripp ML; Smith TL; Li TK; Hesselbrock VM; Bucholz KK
    Am J Psychiatry; 1999 Jan; 156(1):41-9. PubMed ID: 9892296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The DSM-IV field trial for substance use disorders: major results.
    Cottler LB; Schuckit MA; Helzer JE; Crowley T; Woody G; Nathan P; Hughes J
    Drug Alcohol Depend; 1995 Apr; 38(1):59-69; discussion 71-83. PubMed ID: 7648998
    [No Abstract]   [Full Text] [Related]  

  • 8. What's in a word? Addiction versus dependence in DSM-V.
    O'Brien CP; Volkow N; Li TK
    Am J Psychiatry; 2006 May; 163(5):764-5. PubMed ID: 16648309
    [No Abstract]   [Full Text] [Related]  

  • 9. An evaluation of the psychoactive substance dependence syndrome in its application to opiate users.
    Stripp AM; Burgess PM; Pattison PE; Pead J; Holman CP
    Br J Addict; 1990 May; 85(5):621-7. PubMed ID: 2354277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposed changes in DSM-III substance dependence criteria.
    Am J Psychiatry; 1987 Feb; 144(2):257-9. PubMed ID: 3812810
    [No Abstract]   [Full Text] [Related]  

  • 11. Subjective reports of withdrawal among cocaine users: recommendations for DSM-IV.
    Cottler LB; Shillington AM; Compton WM; Mager D; Spitznagel EL
    Drug Alcohol Depend; 1993 Sep; 33(2):97-104. PubMed ID: 8261885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [DSM-5: important changes in the field of addictive diseases].
    Heinz A; Friedel E
    Nervenarzt; 2014 May; 85(5):571-7. PubMed ID: 24737037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should caffeine abuse, dependence, or withdrawal be added to DSM-IV and ICD-10?
    Hughes JR; Oliveto AH; Helzer JE; Higgins ST; Bickel WK
    Am J Psychiatry; 1992 Jan; 149(1):33-40. PubMed ID: 1728182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commonalities and Differences Across Substance Use Disorders: Phenomenological and Epidemiological Aspects.
    Shmulewitz D; Greene ER; Hasin D
    Alcohol Clin Exp Res; 2015 Oct; 39(10):1878-900. PubMed ID: 26332166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DSM-5 criteria for substance use disorders: recommendations and rationale.
    Hasin DS; O'Brien CP; Auriacombe M; Borges G; Bucholz K; Budney A; Compton WM; Crowley T; Ling W; Petry NM; Schuckit M; Grant BF
    Am J Psychiatry; 2013 Aug; 170(8):834-51. PubMed ID: 23903334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current concepts of addiction.
    Jaffe JH
    Res Publ Assoc Res Nerv Ment Dis; 1992; 70():1-21. PubMed ID: 1535926
    [No Abstract]   [Full Text] [Related]  

  • 17. Concordance between DSM-III-R and DSM-IV diagnoses of substance use disorders in adolescents.
    Mikulich SK; Hall SK; Whitmore EA; Crowley TJ
    Drug Alcohol Depend; 2001 Feb; 61(3):237-48. PubMed ID: 11164688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance use disorder: abuse, dependence and dyscontrol.
    Widiger TA; Smith GT
    Addiction; 1994 Mar; 89(3):267-82. PubMed ID: 8173493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excluding a psychoactive substance use disorder in forensic psychiatric evaluations.
    Lacoursiere RB
    J Forensic Sci; 1989 Jan; 34(1):64-73. PubMed ID: 2918289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance use disorders: Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) and International Classification of Diseases, tenth edition (ICD-10).
    Hasin D; Hatzenbuehler ML; Keyes K; Ogburn E
    Addiction; 2006 Sep; 101 Suppl 1():59-75. PubMed ID: 16930162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.